EESTech, Inc financials

EESH CIK 0001138867

Source: EDGAR filings · Built 2026-06-19T02:17:40Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept Q3 2023Q2 2023Q1 2023Q1 2023Q3 2023Q2 2023
Free Cash Flow -788.45K -635.85K -326.89K -905.08K -410.91K
EBITDA -235.98K
Working Capital -572.58K -458.75K -91.00K 135.26K
Operating Margin -284.24% -86930.75% -200.37% -500.41% -320.68%
Net Margin -284.24% -86930.75% -200.37% -500.41% -320.68%
Return on Equity (ROE) -53.95% -54.90% -22.61% -104.61% -159.11%
Return on Assets (ROA) -265.72% -311.79% -48.99%
Current Ratio 0.13× 0.14× 0.83× 1.25×
Cash Conversion Ratio 2.26× 1.55× 1.24× 2.13× 2.33×
Accruals Ratio 3.34× 1.70× 0.12×
CapEx Coverage -26.46× -21.14× -10.71× -108.81× -46.91×
Free Cash Flow Per Share $-0.00 $-0.00 $-0.00 $-0.00

Income Statement

Concept Q3 2023Q2 2023Q1 2023Q1 2023Q3 2023Q2 2023
Operating Income (Loss) -336.61K -392.93K -241.12K -421.65K -172.77K
Net Income (Loss) Attributable to Parent -336.61K -392.93K -241.12K -421.65K -172.77K
Earnings Per Share, Basic $-0.00 $-0.00 $-0.00 $-0.00 $0.00
Weighted Average Number of Shares Outstanding, Basic 273.63M 240.03M

Balance Sheet

Concept Q3 2023Q2 2023Q1 2023Q1 2023Q3 2023Q2 2023
Assets, Current 83.21K 77.04K 437.71K 677.93K
Assets 126.68K 126.03K 492.19K 709.91K
Liabilities, Current 655.79K 535.79K 528.71K 542.67K
Stockholders' Equity Attributable to Parent 623.96K 715.69K 1.07M 1.26M
Common Stock, Shares, Outstanding 276.99M 274.41M 273.63M 273.29M

Cash Flow Statement

Concept Q3 2023Q2 2023Q1 2023Q1 2023Q3 2023Q2 2023
Net Cash Provided by (Used in) Operating Activities -759.74K -607.14K -298.96K -896.84K -402.33K
Payments to Acquire Property, Plant, and Equipment 28.71K 28.71K 27.93K 8.24K 8.58K
Net Cash Provided by (Used in) Investing Activities -28.71K -28.71K -27.93K -8.24K -8.58K
Net Cash Provided by (Used in) Financing Activities 203.31K 35.84K 25.84K 1.25M 577.56K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (EESH CIK 0001138867), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

PBFS

Pioneer Bancorp, Inc./MD

ADIL

ADIAL PHARMACEUTICALS, INC.

FRFFF

FAIRFAX FINANCIAL HOLDINGS LTD/ CAN